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We characterize a sonic hedgehog (Shh) signaling domain re-
stricted to the adventitial layer of artery wall that supports resi-
dent Sca1-positive vascular progenitor cells (AdvSca1). Using
patched-1 (Ptc1lacZ) and patched-2 (Ptc2lacZ) reporter mice, adven-
titial Shh signaling activity was first detected at embryonic day (E)
15.5, reached the highest levels between postnatal day 1 (P1) and
P10, was diminished in adult vessels, and colocalized with a
circumferential ring of Shh protein deposited between the media
and adventitia. In Shh/ mice, AdvSca1 cells normally found at the
aortic root were either absent or greatly diminished in number.
Using a Wnt1-cre lineage marker that identifies cells of neural crest
origin, we found that neither the adventitia nor AdvSca1 cells were
labeled in arteries composed of neural crest-derived smooth mus-
cle cells (SMCs). Although AdvSca1 cells do not express SMC marker
proteins in vivo, they do express transcription factors thought to be
required for SMC differentiation, including serum response factor
(SRF) and myocardin family members, and readily differentiate to
SMC-like cells in vitro. However, AdvSca1 cells also express potent
repressors of SRF-dependent transcription, including Klf4, Msx1,
and FoxO4, which may be critical for maintenance of the SMC
progenitor phenotype of AdvSca1 cells in vivo. We conclude that a
restricted domain of Shh signaling is localized to the arterial
adventitia and may play important roles in maintenance of resi-
dent vascular SMC progenitor cells in the artery wall.
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An adventitia surrounds most blood vessels where it functionsas a dynamic compartment for cell trafficking into and out
of the artery wall. The adventitia is a site for formation and
regression of microvessels that penetrate and nourish the medial
and intimal layers of vessel wall (1–3). The adventitia also
contains perivascular nerves and lymphatic vessels and is an
important domain for NAD(P)H oxidase activity in the vessel
wall (4). Adventitial cells participate in vascular growth and
repair and are important determinants of lumen size via control
of inward or outward wall remodeling processes (2, 5). Recent
studies report unexpected roles for the adventitia insofar as it
supports resident progenitor cells that can adopt both vascular
and nonvascular fates (6–8). Despite these important functional
properties, the signals and environmental cues that confer such
unique and dynamic properties to the adventitial layer remain
largely unknown.
Sonic hedgehog (Shh) is an essential morphogen and growth
factor for many developing tissues (9). In the vascular system,
Shh signaling is important for specification of arterial-venous
identity of endothelial cells (10), remodeling of yolk sac blood
vessels (11), and recruitment of mural cells (12). In adult blood
vessels, Shh is angiogenic in ischemic hindlimb and corneal
micropocket assays (13, 14), promotes perineural neovascular-
ization in diabetic animals (15), and protects the myocardium
against chronic ischemia (16). Shh stimulates production of
angiogenic factors, including VEGF-A and angiopoietin-1 by
interstitial fibroblasts (13, 14), and promotes endothelial cell
chemotaxis and tube formation (17, 18). Therefore, Shh plays
important roles in cell–cell communication during vascular
development and adult wound repair.
Hedgehog (Hh) proteins signal by binding to patched-1 (Ptc1)
or patched-2 (Ptc2) receptors and cdo/boc accessory proteins at
the cell surface, resulting in derepression of smoothened (smo)
(19). Ptc proteins are 12-transmembrane domain receptors that
are structurally related to the resistance-nodulation-division
(RND) family of bacterial membrane permeases (20) and the
Niemann-Pick C1-like1 cholesterol transporter (21). Ptc proteins
contain a conserved sterol-sensing domain, and recent studies
suggest that Ptc1 represses smo by transporting activating sterols
out of the cell (22). Hh binding to Ptc1 inhibits transporter
activity thereby allowing activating sterols to accumulate (19,
22). Activated smo trafficks into the primary cilium where Hh
signal mediators are concentrated (23, 24) and triggers phos-
phorylation of gli factors that then move to the nucleus and
stimulate gene transcription (25). Among Hh target genes are
Ptc1 and Ptc2; therefore, Ptc1lacZ and Ptc2lacZ activities are used
as sensitive reporters of Hh signaling in transgenic mice (26, 27).
The origins and functions of the adventitia are poorly under-
stood. Hu et al. (6) reported that stem cell antigen-1 (Sca1)-
positive cells with a potential to differentiate into smooth muscle
cells (SMCs) were found in the aortic adventitia of adult
ApoE/ mice (AdvSca1 cells). When transferred to the adven-
titial side of experimental vein grafts, AdvSca1-derived SMCs
made up 30% of cells in the graft neointima after 4 weeks (6).
The adventitia responds to balloon catheter injury with rapid
increases in SMActin and SM22 expression, particularly at the
media–adventitia interface (5). Endothelial progenitor cells are
reported to cluster between the media and adventitia in human
arteries (7, 8). These cells formed capillary sprouts in ex vivo ring
culture assays and were recruited by tumor cells for capillary
vessel formation in vivo. Given the role of Shh signaling in the
maintenance of resident stem and progenitor cells in skin (28),
nervous system (29), lymphoid tissue (30), and hematopoietic
cells (31), we sought to test for similar roles for Hh signaling in
the adventitial tissue surrounding blood vessels.
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Hh Signaling in Postnatal Blood Vessels. We examined -gal activity
in blood vessels of PtclacZ transgenic mice at postnatal day 2 (P2).
In whole-mount hearts, Ptc1lacZ and Ptc2lacZ activities were
detected in coronary arteries, but not in myocardium or epicar-
dium (Fig. 1A). The ascending aorta and pulmonary trunk were
strongly positive at this time (Fig. 1 A). Both Ptc1lacZ and Ptc2lacZ
activities declined with age and were detected at low levels in
coronary arteries and transverse aorta from adult mice (Fig. 1B).
In aortic cross-sections at P2, strong Ptc1lacZ activity was re-
stricted to the adventitia, with only an occasional positive cell
found in the media or intima (Fig. 1C). Adventitial Ptc1lacZ
activity was also found in intercostal (Fig. 1D) and femoral (Fig.
1F) arteries. In the mesenteric arcade, Ptc1lacZ staining of
arteries was more intense than that of veins (Fig. 1E), whereas
lymphatic vessels were negative [supporting information (SI)
Fig. S1]. Ptc2lacZ activity exhibited very similar patterns (Fig. 1
D–F Right and Fig. S2). Thus, active Hh signaling was found in
large and medium-sized arteries and veins in the perinatal period
and was localized to the adventitia of these vessels.
Shh in the Adventitia. Shh protein was localized to the interface
between the media and adventitia in large and medium-sized
arteries 2 days after birth (Fig. 2A). This pattern of Shh
distribution colocalized with both Ptc1lacZ (Figs. 1C and 2B Inset)
and Ptc2lacZ activities. We could not detect Indian hedgehog
(Ihh) in postnatal arteries and found only low levels of desert
hedgehog (Dhh) in the endothelium (data not shown). These
results indicate that Ptc1lacZ and Ptc2lacZ activities in the artery
wall correlate with localized deposition of Shh protein in a
circumferential ring in the extracellular matrix (ECM)-rich space
between the media and adventitia (Fig. 2 A).
Sca1-Positive Cells in the Adventitia. A previous report (6) de-
scribed Sca1 cells in the adventitia surrounding the aortic root
in adult ApoE/ mice. One possible role of Shh may therefore
be to maintain Sca1 progenitor cells within this domain of
artery wall. As shown in Fig. 2C, Sca1 cells are restricted to the
adventitia (AdvSca1 cells) and exhibit little or no overlap with
SMActin-positive cells in the media. A similar distribution was
found in mesenteric and femoral arteries (Fig. 2 E and F). Close
proximity was found between Shh protein and AdvSca1 cells
(Fig. 2D). Extensive overlap was observed between -gal-
positive cells and AdvSca1 cells in the aortic adventitia of Ptc1lacZ
mice (Fig. 2D Inset). These findings suggest that a zone of Shh
signaling in the adventitia identifies a unique domain of artery
wall within which resident Sca1 vascular progenitor cells are
found in vivo.
Analysis of Isolated AdvSca1 Cells. AdvSca1 cells were isolated by
immunoselection and examined for progenitor cell markers.
AdvSca1 cells exhibited a CD34/c-kit/CD140b marker pro-
file (Fig. 3A) and were negative for CD45 and CD68 (data not
shown), similar to the profile reported by Hu et al. (6). Freshly
isolated AdvSca1 cells consistently expressed markers of Shh
signaling including ptc1, ptc2, smo, gli1, gli2, and gli3 (Fig. 3A).
The distribution of Shh in the extracellular space is governed by
multiple binding and transport proteins including hedgehog
interacting protein-1 (Hhip1), cdo, and boc (reviewed in ref. 19),
all of which are expressed by AdvSca1 cells (Fig. 3A). In addition,
AdvSca1 cells contain mRNA for Shh, with few, if any, tran-
scripts detectable for Dhh or Ihh (Fig. 3A). These results suggest
that AdvSca1 cells both produce and respond to Shh, and that the
restricted distribution of Shh in the artery wall is, in part, locally
controlled by factors produced by AdvSca1 cells themselves.
Hu et al. (6) reported that AdvSca1 cells differentiate into
SMCs when incubated with PDGF-BB (6). We found that when
cultured in DMEM containing 10% serum many AdvSca1 cells
(30–50%) lost expression of Sca1, gained expression of
SMActin, SM22, calponin, and SM-MHC, and adopted an
elongated, mesenchymal cell shape (Fig. 3 D and E). To rule out
the possibility that up-regulation of SMC markers resulted from
expansion of a pool of medial SMCs carried over in the AdvSca1
cell isolation, we repeated our experiments in the presence of
inhibitors of cell proliferation (aphidicolin or hydroxyurea).
After verifying growth arrest, we observed up-regulation of SMC
marker proteins over a similar time course and to a similar extent
as seen in the absence of cell cycle inhibitors (Fig. S3). We
conclude that AdvSca1 cells can directly differentiate into
Fig. 1. Hh signaling in artery wall. (A, B, and D–F ) Tissues were isolated from PtclacZ mice at P2 and stained for -gal activity. All major arteries examined,
including coronary arteries, aorta, pulmonary trunk (A), intercostal (D), mesenteric (E), and femoral arteries (F ) were positive for Ptc1lacZ or Ptc2lacZ activity as
shown. (B) Adult hearts displayed low levels of -gal activity in coronary arteries, aorta, and pulmonary artery. (C) A cross-section of the aorta at P2 reveals
Ptc1lacZ-positive cells are restricted to the adventitia. Ica, intercostal artery; A, artery; V, vein; N, nerve. (Magnification: A and D–F, 7; B, 3; C,  40.)
9350  www.pnas.orgcgidoi10.1073pnas.0711382105 Passman et al.
SMC-like cells, and that this differentiation does not require cell
proliferation.
AdvSca1 cells do not express SMC marker proteins in vivo
(Figs. 2 and 4). However, they contain mRNAs for transcription
factors involved in SMC differentiation, including serum re-
sponse factor (SRF), myocardin family members, and cysteine-
rich LIM proteins Csrp1 and Csrp2 (Fig. 3A). In addition, a
subset of freshly isolated AdvSca1 cell nuclei were immunopo-
sitive for SRF protein (Fig. 3B). However, AdvSca1 cells also
express potent silencers of SRF-dependent transcription, includ-
ing Msx1, Klf4, and FoxO4 (Fig. 3D and data not shown). Each
of these factors can inhibit SRF and myocardin-dependent SMC
gene expression (32, 33), and they are down-regulated as Ad-
vSca1 cells acquire SMC markers and increase SRF coactivator
expression (Fig. 3D). Therefore, a subset of AdvSca1 cells may
be maintained as SMC progenitors by expression of silencers of
SRF-dependent transcription. When AdvSca1 cells were incu-
bated with VEGF-A (10 ng/ml, 9 days), PECAM1-positive
endothelial cell clusters appeared in elongated cords that often
colocalized with SMActin-positive cells (Fig. S4). When incu-
bated with BMP2 (50 ng/ml, 20 days), colonies formed that
stained with alizarin red or von Kossa’s stain consistent with
differentiation of a subset of AdvSca1 cells to osteogenic cells
(Fig. S4). Under conditions described above, 30–50% of Ad-
vSca1 cells differentiated to SMC-like cells, 10% produced
endothelial cells, and 1–5% formed osteogenic colonies in vitro.
Developmental Origins of AdvSca1 Cells. Bone marrow reconstitu-
tion experiments previously showed that AdvSca1 cells are not
marrow-derived (6). To gain insight into the origins of AdvSca1
cells in vivo we examined mice from embryonic day 12.5 (E12.5)
to 12 weeks after birth. AdvSca1 cells first appeared in the
perivascular space between the ascending aorta and pulmonary
trunk between E15.5 and E18.5 (Fig. 4C, arrows), well after the
tunica media had acquired SMCs and organized a full comple-
ment of elastic lamellae. AdvSca1 cells were present in this
position at all subsequent time points examined, and they
increased in number with postnatal growth of the artery wall
(Fig. 4 D–F). We then used Wnt1-cre transgenic mice to label
cells of neural crest origin (34). Wnt1-cre-activated -gal reporter
labeled neural crest-derived SMCs in proximal aorta, pulmonary
trunk, common carotid arteries, and ductus arteriosus, but did
not label AdvSca1 cells in these vessels (Fig. 4 G and H).
Analysis of AdvSca1 Cells in Shh/ Embryos. To determine whether
Shh was required for the formation or maintenance of AdvSca1
cells, we examined Shh/ mice. Two anatomically defined sites
were studied. The presence of AdvSca1 cells at the aortic root,
where they are first detected during development (Fig. 4C) and
are most abundant in adult ApoE/ mice (6), was confirmed in
WT mice (Fig. 5A). By contrast, we could not detect AdvSca1
cells at the aortic root in Shh/ embryos (Fig. 5B). A small
number of AdvSca1 cells were found in the transverse portion of
thoracic aorta (Fig. 5 E and F). An absence of septation of the
common truncus arteriosus in Shh-deficient embryos has been
described (35). AdvSca1 cells were present in the descending
thoracic aorta of Shh/ embryos, but always in reduced num-
bers (Fig. 5 C–F and Fig. S5). The presence of residual AdvSca1
cells suggests that factors other than Shh are involved in homing
and/or maintenance of these cells. Because Dhh expression was
detected in the aorta, low levels of Dhh may allow some of these
cells to escape a requirement for Shh in the artery wall.
Fig. 2. Distribution of Shh and Sca1 cells in the adventitia. (A) Shh protein
is found outside the aortic external elastic lamina (marked by green autofluo-
rescence) at P2. (B) Shh protein (red) is found between the media (SMActin,
green) and adventitia of descending aorta. (B Inset) Shh (red) is colocalized
with -gal in aortic sections from Ptc1lacZ mice. (C) Sca1 cells (red) reside
outside the media (SMActin, green) in P2 aorta. (D) Sca1 cells (green) are
found in close proximity to Shh (red) and are embedded within a -gal-positive
domain (Inset) in aortic adventitia from Ptc1lacZ mice. (E) Mesenteric vessels
stained for SMActin (green) and Shh (red). (F ) Femoral arteries stained for
SMActin (green) and Sca1 (red). Images are stacked Z-plane sections from
confocal microscopy. Adventitial localization of Sca1 cells correlates with the
distribution of Shh protein and active Shh signaling in vivo.
Fig. 3. Analysis of AdvSca1 cells. (A) RT-PCR analysis of AdvSca1 cells from
adult arteries. (B) Freshly isolated AdvSca1 cells (red) contain SRF (green)
colocalized with DAPI-stained nuclei (blue) (arrows). (C) Freshly isolated
AdvSca1 cells (red) contain Klf4 (green) colocalized with DAPI-stained nuclei
(blue) (arrows). (D) RT-PCR analysis of AdvSca1 cells cultured for 0, 12, or 28
days. M is total RNA from aortic media used as a positive control for SMC
markers. This analysis was performed three times with similar results. (E)
AdvSca1 cells cultured in serum-containing medium for 9 days. Many cells
down-regulate ScaI (red) and up-regulate SMActin (green). (Magnifications:
B and C, 40; E, 10.)












We report the characterization of a Shh signaling domain in the
adventitial layer of vessel wall. This domain is strongly positive
for both Ptc1lacZ and Ptc2lacZ activities and colocalizes with a ring
of Shh protein deposited between the media and adventitia.
Embedded within this domain is a population of Sca1-expressing
vascular progenitor cells, termed AdvSca1 cells, that can differ-
entiate to SMC-like cells ex vivo. The number of AdvSca1 cells
in the aortic root is greatly diminished in Shh/ mice at E18.5.
These findings suggest that Shh signaling may play important
roles in development of the adventitia and maintenance of a
resident population of Sca1 vascular progenitor cells in the
artery wall.
Hh Signaling in Postnatal Artery Wall. Ptc1lacZ and Ptc2lacZ activi-
ties in the adventitia of large and medium-sized arteries were
greatest between 1 and 10 days after birth. Although the basic
structure of major arteries is established at birth, substantial
growth and remodeling occur in the perinatal period. For
example, the number of SMCs in rat aorta increases 2.5-fold,
wall thickness doubles, and collagen and elastin contents
increase 3-fold in the first month after birth (36). These
changes in wall structure are adaptations to large perinatal
increases in blood f low and blood pressure that are accom-
panied by corresponding increases in smooth muscle contrac-
tile protein mass (37). After 3 months of age, growth of the
artery wall is diminished, cell proliferation rates are low, and
wall structure has reached an adult state. We found PtclacZ
activities and Shh protein levels were maintained at low levels
in adult mouse arteries, suggesting that adventitial Shh sig-
naling activity correlates with rapid postnatal growth and
remodeling of the artery wall.
Distribution of Shh in the Adventitia. Ptc1lacZ and Ptc2lacZ activities
were colocalized with Shh protein deposited between the media
and adventitia. Movement of Hh proteins in the extracellular
space is limited by covalent lipid modifications at both amino-
and carboxyl-terminal domains (38, 39). Lipid-modified Hh
proteins are secreted as multimers that interact with heparan
sulfate proteoglycans (HSPGs), which further restricts their
movement (40, 41). Our data suggest that Shh protein is con-
centrated between the media and adventitia because of local
synthesis, secretion, and retention of Shh multimers by ECM
components, such as the HSPG perlecan (42), in the artery wall.
PtclacZ-positive cells are located throughout the adventitia,
whether directly adjacent to Shh protein at the media-adventitia
interface or several cell layers removed. We do not yet know
whether this pattern of PtclacZ activity in vivo is the result of
paracrine secretion of Shh by AdvSca1 cells themselves, ECM
retention of Shh produced from another source, or some com-
bination of both. However, freshly isolated AdvSca1 contain
readily detectable amounts of Shh mRNA, suggesting that local
synthesis and secretion of Shh is a normal function of the arterial
adventitia.
Fig. 4. AdvSca1 cells in developing aorta. (A–F ) Tissues were obtained at the
time points indicated. Cross-sections through the aortic root were stained for
Sca1 (red), SMActin (green), and DAPI (blue). AdvSca1 cells first appear
between E15.5 and E18.5 in the adventitial space between aorta and pulmo-
nary trunk (white arrows in C) and persist in this location into adulthood. (G)
Cross-section from Wnt1-cre/R26R (5 weeks old) aortic root stained for -gal
activity and nuclear fast red. SMCs (blue) but not adventitial cells originate
from neural crest. Dashed box is shown at higher magnification in H. (H)
Cross-section through aortic root shows no overlap between -gal-positive
and AdvSca1 cells. Ao, aorta; PT, pulmonary trunk. (Magnification scale bar
in E applies to A–F; G, 10.)
Fig. 5. AdvSca1 cells in Shh/ arteries. (A–D) Aortic tissues from WT (A and
C) and Shh/ (B and D) embryos at E18.5. Cross-sections through aortic root
(A and B) and descending aorta (C and D) were immunostained for Sca1 (red),
SMActin (green), and DAPI (blue). (E) Solid lines in indicate relative positions
of sections in A–D. (F ) Dotted line boxes in A–D correspond to aortic segments
shown here. AdvSca1 cells are absent in aortic root, greatly reduced in as-
cending and transverse aorta (termed ascending), and diminished in descend-
ing aorta of Shh/ embryos.
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Analysis of Isolated AdvSca1 Cells. Embedded within the PtclacZ-
positive adventitial domain, we found a population of Sca1-
expressing cells that were negative for marker proteins of
differentiated SMCs. However, when removed from the ad-
ventitia and placed in serum-containing medium, a significant
fraction (30–50%) of these cells lost Sca1 from the cell
surface, acquired a well spread mesenchymal cell shape, and
expressed the SMC marker proteins SMActin, SM22, cal-
ponin, and SM-MHC by 12–28 days. When AdvSca1 cells were
exposed to BrdU to label replicating cells, a significant number
of Sca1–BrdU double positive cells were found after 7 days,
indicating that some AdvSca1 self-renew while, at the same
time, others differentiate to SMC-like cells under the same
conditions (Fig. S3). These results suggest that AdvSca1 cells
are a heterogeneous mixture of cells that can either self-renew
or respond to extracellular signals and differentiate to SMC-
like cells in vitro.
Maintenance of a Progenitor Phenotype by Transcriptional Corepres-
sors. AdvSca1 cells do not express SMC marker proteins in vivo.
It was intriguing, therefore, to find that AdvSca1 cells con-
tained transcripts for SRF and myocardin family members and
were immunopositive for SRF when examined immediately
after isolation from the artery wall. These transcription factors
are strong activators of SMC gene expression (37, 43–45) and
are necessary for vascular SMC differentiation in vivo. Yet
SRF also interacts with potent transcriptional corepressors,
and it is the competition between coactivators and corepres-
sors that determines whether SRF-dependent target genes are
transcribed (44–48). Indeed, we found that the transcriptional
corepressors Msx1, Klf4, and FoxO4 were also expressed by
AdvSca1 cells. Msx1 forms a ternary complex with SRF and
myocardin and inhibits binding of SRF-myocardin to CArG
box motifs in SMC target genes (32). Klf4 is a zinc finger-
containing protein that binds to a GC-rich element (TCE) and
inhibits SRF-dependent transcription of multiple SMC marker
genes (47). The forkhead transcription factor FoxO4 interacts
with myocardin and inhibits its coactivator function for SRF-
dependent SMC gene expression (49). These results are rem-
iniscent of a report by Matsuura et al. (50), showing that Sca1
cells from adult mouse hearts express Nkx2–5 and GATA4,
two transcription factors important for cardiac myocyte dif-
ferentiation, yet they do not express markers of differentiated
myocardial cells. Heart-derived Sca1 cells differentiate to
beating cardiomyocytes when exposed to oxytocin in vitro, thus
confirming their cardiogenic potential (50). These findings in
heart and artery wall suggest a model in which Sca1 progen-
itor cells in postnatal tissues are specified for certain cell fates
by expression of transcription factors that are required for
those fates. The maintenance of a SMC progenitor phenotype
may therefore critically depend on expression of transcrip-
tional corepressors that block SRF-dependent transcription
and recruit chromatin remodeling complexes to silence gene
expression.
Origins of AdvSca1 Cells. The origins of AdvSca1 cells are unclear.
Hu et al. (6) found no evidence that AdvSca1 cells arise from
bone marrow. We investigated this question for aortic AdvSca1
cells by using Wnt1-cre transgenic mice in which -gal is
permanently expressed in neural crest-derived cells (34). Ad-
vSca1 cells directly adjacent to Wnt1-cre-positive aortic SMCs
did not express the neural crest marker. Moreover, our devel-
opmental time course studies showed that AdvSca1 cells did
not appear in aortic arch arteries until between E15.5 and
E18.5, much later than the migration of neural crest-derived
SMC progenitors into the aortic arch complex E9.5. Two
other lineages contribute SMCs to the aorta and other great
vessels, i.e., paraxial somitic mesoderm and secondary heart
field (51). Lineage-specific cre mice are available for both of
these progenitors to test whether AdvSca1 cells arise from
either of these sources.
Summary. We characterize a novel domain of Shh signaling in
the arterial adventitia and show that a population of Sca1
vascular progenitor cells resides within this domain. Because
the adventitia lies between the vessel wall and surrounding
tissues, progenitor cells within the adventitia could, in prin-
ciple, contribute to remodeling, repair, or disease processes in
either the vessel wall or in neighboring nonvascular tissues.
Because essentially all tissues of the body contain blood
vessels, the maintenance and fate of adventitial progenitor
cells described here and by Hu et al. (6) may be relevant to a
wide variety of normal and pathogenic processes. Future work
will examine the role of Hh signaling in responses of the
adventitia to tissue injuries involving both vessels and sur-
rounding nonvascular cell types.
Materials and Methods
Animals Used. All protocols were approved by the Institutional Animal Care
and Use Committee at the University of North Carolina. Mice used include
Ptc1lacZ (Ptctm1Mps) (26), Ptc2lacZ (Ptc2tm1Dgen; Jackson Laboratories; 005827),
Wnt1cre (Jackson Laboratories; 003829), Shhtm1Amc (Jackson Laboratories;
003318), Rosa26 (52), CD1 (Charles River), 129/SvEvJ and C57BL/6J (Jackson
Laboratories). Noon on the day of vaginal plug was designated E0.5.
Whole-Mount -Gal Activity. Embryos or tissues were fixed in fresh 0.2%
glutaraldehyde in 0.1 M sodium phosphate, 5 mM EGTA, 2 mM MgCl2, pH 7.3,
for 1 h on ice, washed three times with rinse buffer (10 mM sodium phosphate,
2 mM MgCl2, and 0.1% Triton X-100, pH 7.4) for 30 min each at room
temperature, and stained as described in SI Text.
Immunofluorescence Staining. Tissues were fixed in 4% paraformaldehyde
(PFA), rinsed in PBS, saturated with 20% sucrose for cryoprotection, embed-
ded in agar, and frozen in OCT. Cryosections (12 m) were fixed and stained
as described in SI Text. Cultured cells were fixed in 4% PFA for 15 min at room
temperature, then stained as described in SI Text. Primary antibodies and
imaging methods are described in SI Text.
AdvSca1 Cell Isolation and Culture. The ascending aorta, aortic arch, and 1
cm of the descending aorta were dissected from adult mice and placed in
PBS on ice. Endothelium was removed with a cotton swab. Adventitia was
dissected and rinsed in HBSS, digested with 14 mg/ml collagenase type 2
(Worthington) and 0.75 mg/ml elastase (Roche) in HBSS for 2 h at 37°C with
gentle rocking, and filtered (70 m). Cells in the filtrate were pelleted at
300  g then rinsed in PBS  0.5% BSA. Aortic Sca1 cells were isolated by
using anti-Sca1 immunomagnetic MicroBeads and a MACS cell separation
system (Miltenyi). Cells were passed over two consecutive columns to
increase purity of the isolation. A typical Sca1 fraction thus prepared is
1– 4% of total cells, with 80 –95% of isolated cells positive for Sca1 antigen,
and 1% of isolated cells positive for SMActin by immunostaining.
Isolated Sca1 cells were cultured in DMEM (Sigma) plus 10% FBS (HyClone)
and 1 antibiotic/antimycotic solution (Gibco) at 37°C, 5% CO2. Cells were
seeded in 48-well tissue culture plates at 8  103 cells per well. Growth
factors tested were VEGF-A (10 ng/ml; Clonetics) and BMP2 (50 ng/ml,
PeproTech).
RT-PCR Analysis. Total cellular RNA was isolated by guanidinium isothiocya-
nate denaturation and phenol/chloroform extraction as described (53). Two-
step RT-PCR was carried out with the GeneAmp RNA PCR kit (Applied Biosys-
tems) according to the manufacturer’s instructions. Primer sequences and PCR
conditions are listed in Table S1.
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